A dengue fever outbreak in Samoa – formally declared by the Samoan Ministry of Health in April 2025 and acknowledged in a health sub-advisory by the Australian government – creates two separate coverage problems for travel insurance policyholders. Brokers placing Pacific travel need to understand both before a client travels, because neither issue resolves itself at claims time.
Samoa retains a Level 1 “Exercise normal safety precautions” designation on Smartraveller. That matters because it means the destination advisory exclusion – which applies when a “Reconsider your need to travel” or “Do not travel” alert is in place – does not automatically void a policy. What it does not mean is that a dengue claim is straightforwardly covered.
The first exposure comes from epidemic and pandemic exclusions. Allianz Australia’s current travel insurance product terms, published on its website, state that its Comprehensive Travel Insurance “has a general exclusion, with limited exceptions, against epidemics and pandemics. That means we don’t cover claims that arise from, or are related to, an epidemic or pandemic.” Samoa’s Ministry of Health has declared a dengue outbreak. Whether an individual insurer classifies that outbreak as an “epidemic” for the purposes of this exclusion is a question brokers must put directly to each insurer – the answer will vary by PDS.
The second exposure is the known-event exclusion. Allianz Australia’s product terms state that “there is no cover under any benefit of this policy if your claim arises because you didn’t follow advice or a warning that has been issued by the Australian government or a reliable mass media source.” Smartraveller’s advisory for Samoa, last updated August 5, 2026, explicitly states that Samoa’s Ministry of Health has declared a dengue outbreak and that healthcare systems are facing pressures with the increasing number of cases. That advisory has been live, in updated form, since at least April 2025. The Insurance Council of Australia (ICA) confirms the industry position: most travel insurance policies have exclusions for outbreaks of infectious diseases, pandemics, epidemics, and/or known events.
From January 1 through June 11, 2026, more than 3,500 confirmed dengue cases, 156 hospitalisations, and three deaths were reported across the Pacific region. Six Pacific island countries and territories – American Samoa, Kiribati, New Caledonia, Samoa, Tonga, and Tuvalu – were reporting active outbreaks as of June 11, with New Caledonia recording the highest case numbers in 2026.
For any claim that does respond, the financial exposure is high. Smartraveller is explicit: hospital and medical facilities in Samoa are very limited, all foreigners must pay for health services – with cash typically required before treatment – and in the event of a medical emergency, evacuation by air to Australia or New Zealand is likely the only option. There is no helicopter service, blood supplies are often limited, and medical evacuations may be delayed if commercial airlines are used. Smartraveller states that Australians should hold comprehensive travel insurance covering medical evacuations, noting the Australian government will not pay for these costs.
Under Australian law, a general insurance broker who is a licensee or authorised representative must provide financial services efficiently, honestly, and fairly. The National Insurance Brokers Association (NIBA) Insurance Brokers Code of Practice requires brokers to act honestly and with integrity and to communicate with clients in a clear and timely manner. Where the insurance market offers different terms that might meet a client’s needs, the broker should take care to explain the range of available cover and the advantages and disadvantages of each, so the client can make an informed choice.
Where an active outbreak has been publicly declared at a destination, a broker who places a policy without advising the client that dengue fever may fall within an epidemic exclusion, or within the policy’s known-event provisions, is not meeting that standard. ICA CEO Andrew Hall made the disclosure expectation clear in October 2025: “Understanding your policy and assessing what kinds of activities you plan on undertaking while you’re travelling is the best way to make sure you’re protected. Check Product Disclosure Statements and speak directly to insurers with any questions.”
The 2025 ICA and DFAT Travel Insurance Survey, a national survey of 1,001 Australian travellers, found that while around 70% of respondents were aware of Australian government travel advisories, almost half were unaware that travel insurance would likely not cover travel to destinations subject to a Level 4 (“Do not travel”) advisory. Awareness was lower among younger travellers, who were more likely to underestimate the impact of travel advisories on insurance cover. Samoa’s Level 1 status is precisely the condition that creates false comfort. One in seven Australian travellers went overseas without any cover at all, with one in three of those who skipped insurance deciding against it because they considered their destination safe.
Australians comprised 24% of all visitors to Samoa in the first half of 2025, making Australia the second-largest source market after New Zealand. For brokers with clients travelling to Samoa now, three actions are non-negotiable: confirm with each insurer how it classifies the Samoa dengue outbreak under its epidemic and known-event exclusions; verify that medical evacuation cover is explicitly included; and document the advice provided to the client. The Australian Financial Complaints Authority (AFCA) complaints environment – where general insurance complaints rose 17% to 34,231 in 2024-25, with denial of claim based on exclusion among the leading complaint categories – makes that documentation commercially as well as professionally important.
